REYATAZ (E.R. Squibb & Sons, L.L.C.)
Welcome to the PulseAid listing for the REYATAZ drug offered from E.R. Squibb & Sons, L.L.C.. This HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],UGT1A1 Inhibitors [MoA],UDP Glucuronosyltransferases Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | E.R. Squibb & Sons, L.L.C. |
| NON-PROPRIETARY NAME: | ATAZANAVIR |
| SUBSTANCE NAME: | ATAZANAVIR SULFATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],UGT1A1 Inhibitors [MoA],UDP Glucuronosyltransferases Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | POWDER |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2014-12-19 |
| END MARKETING DATE: | 0000-00-00 |
REYATAZ HUMAN PRESCRIPTION DRUG Details:
| Item Description | REYATAZ from E.R. Squibb & Sons, L.L.C. |
| LABELER NAME: | E.R. Squibb & Sons, L.L.C. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/1) |
| START MARKETING DATE: | 2014-12-19 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0003-3638_5cada4d1-f42d-4412-ad98-01fd73a2ac57 |
| PRODUCT NDC: | 0003-3638 |
| APPLICATION NUMBER: | NDA206352 |
Other ATAZANAVIR SULFATE Pharmaceutical Manufacturers / Labelers:
